Islamabad, March 19, 2025 – Pakistan and Denmark have agreed to expand ongoing collaboration in healthcare, focusing on improving access to essential treatments and strengthening Pakistan’s health infrastructure.
Key Developments
- Federal Health Minister Syed Mustafa Kamal reaffirmed the government’s commitment to facilitating business opportunities in the health sector.
- Danish Ambassador met with Minister Kamal to discuss existing and future healthcare collaborations.
- Pakistan emphasized the need for foreign investment to address public health challenges.
Major Discussion Points
- Diabetes Crisis: Pakistan has 33 million diabetic patients, highlighting the urgent need for insulin access.
- Local Insulin Production:
- Novo Nordisk is currently the only Danish company supplying insulin to Pakistan.
- Minister Kamal proposed importing raw materials to produce insulin locally, reducing dependency on direct imports.
- Denmark plans to establish repackaging facilities in Pakistan as an initial step toward localized production.
The meeting underscores Pakistan’s strong ties with Denmark and the potential for enhanced medical collaboration, including pharmaceutical production and disease management initiatives.
Would you like updates on Danish investments in Pakistan’s health sector or local insulin production developments?
